Scientists have discovered a new type of anti-malarial antibody that doesn't interfere with current vaccines, at least in ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

Researchers from the Massachusetts Institute of Technology (MIT) and the California Institute of Technology (Caltech) have made significant strides in vaccine development that could protect against ...

The researchers say antibodies in this class are particularly promising because they bind to regions of the malaria parasite not included in current malaria vaccines, providing a potential new ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's ...

The global antibody drug conjugates market size was valued at USD 11.84 billion in 2024 and is projected to reach from USD 12 ...

Results: We present an allelic atlas of immunoglobulin heavy chain (IgH) variable regions, illustrating the diversity of allelic variants across 33 IGHV family germline sequences by sequencing the IgH ...

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...

The technique, which focuses on modeling the hypervariable regions of antibodies, also holds potential for analyzing entire antibody repertoires from individual people. This could be useful for ...

The discovery of the pGlu-CSP epitope opens up new avenues for developing next-generation malaria vaccines and treatments. The researchers are optimistic that this new class of antibodies could ...